• Publishes critical reviews of broad interest on the treatment of neurologic disorders by renowned experts.
  • Covers emerging treatments for neurologic disorders.
  • Publishes cutting edge original translational research in unmet medical needs for diseases of the nervous system.
  • Explores the molecular underpinnings of neurologic diseases as rationale for targeted therapies.
  • Provides a platform for publishing points-of-view by key opinion leaders on current hot topics.

Journal information

Editor-in-Chief
  • M. Maral Mouradian
Publishing model
Hybrid (Transformative Journal). Learn about publishing Open Access with us

Journal metrics

6.035 (2019)
Impact factor
6.453 (2019)
Five year impact factor
21 days
Submission to first decision
111 days
Submission to acceptance
597,939 (2020)
Downloads

Latest issue

Volume 17

Issue 1, December 2020

Huntington Study Group Abstracts 2020

This is a supplement

Latest articles

Journal updates

  • Announcement: COVID-19 impact on peer review

    As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

  • Future Theme Issues

    January 2021 
    Therapeutic Frontiers in Sleep Neurology

    Guest Editors:  Aleksander Videnovic (Harvard) and Erik St. Louis (Mayo)


    April 2021
    Neurotherapeutics on Neuroimaging Advances in Neurologic /Neurodegenerative Diseases

    Guest Editors:  Andrew Saykin and Shannon Risacher (IUPUI)


    July 2021
    Precision Treatments in Epilepsy

    Guest Editors:  Amy Brooks-Kayal and Scott Demarest (Children's Colorado)


    October 2021
    Neurotherapeutics on Peripheral Neuropathy

    Guest Editors:  Michael Polydefkis and Charlotte Sumner (JHMI)

View all updates

Societies, partners and affiliations

Subscribe

eJournal
$79.00
Note this is only the net price. Taxes will be calculated during checkout.
  • Immediate online access with complete access to all articles starting 1997
  • Downloadable in PDF format
  • Subscription expires 12/31/2021

About this journal

Electronic ISSN
1878-7479
Print ISSN
1933-7213
Abstracted and indexed in
  1. CNKI
  2. Chemical Abstracts Service (CAS)
  3. Current Contents/ Life Sciences
  4. Current Contents/Clinical Medicine
  5. Dimensions
  6. EBSCO Biomedical Reference Collection
  7. EBSCO CINAHL
  8. EBSCO Discovery Service
  9. EMBASE
  10. Google Scholar
  11. Institute of Scientific and Technical Information of China
  12. Japanese Science and Technology Agency (JST)
  13. Journal Citation Reports/Science Edition
  14. Medline
  15. Meta
  16. Naver
  17. OCLC WorldCat Discovery Service
  18. ProQuest Biological Science Database
  19. ProQuest Central
  20. ProQuest Health & Medical Collection
  21. ProQuest Health Research Premium Collection
  22. ProQuest Medical Database
  23. ProQuest Natural Science Collection
  24. ProQuest Neurosciences Abstracts
  25. ProQuest Nursing & Allied Health Database
  26. ProQuest Pharma Collection
  27. ProQuest Psychology Database
  28. ProQuest SciTech Premium Collection
  29. ProQuest-ExLibris Primo
  30. ProQuest-ExLibris Summon
  31. PubMedCentral
  32. Reaxys
  33. SCImago
  34. SCOPUS
  35. Science Citation Index Expanded (SciSearch)
  36. TD Net Discovery Service
  37. UGC-CARE List (India)
Copyright information

Rights and permissions

Springer policies

© The American Society for Experimental NeuroTherapeutics, Inc.